Several pharma CEOs met with Chinese President Xi Jinping in Beijing. President Donald Trump's reciprocal tariffs have mostly ...

TOKYO -- Japanese trading house Marubeni said Tuesday it will purchase a majority stake in Sumitomo Pharma's drug sales business in Asia for roughly 45 billion yen ($301 million).

Lim Siew Khee and Meghana Kande of CGS International have revised their target prices for Sembcorp Industries from $7.41 to ...

Sumitomo Pharma Co. Ltd. announced that it will sell off two more of its subsidiaries, Sumitomo Pharma (China) Co. Ltd. and Sumitomo Pharma Asia Pacific Pte. Ltd. (and their subsidiaries), to Marubeni ...

In the latest in a growing trend of pharma reshuffling moves in Asia, Marubeni Corporation is absorbing Sumitomo Pharma’s ...

Japanese drugmaker Sumitomo Pharma said yesterday that it is divesting its Asian business to major Japanese trading house ...

Its wholly owned subsidiary, Sembcorp Utilities, has signed a sale and purchase agreement to increase its interest in Senoko ...

SINGAPORE] Sembcorp Industries is moving to raise its stake in energy supplier Senoko Energy that could potentially more than ...

SINGAPORE] Sembcorp Industries is proposing an acquisition in energy supplier Senoko Energy that could potentially more than ...

Vikrant Aggarwal will succeed Mike Odell, who will remain as chief executive officer of Marubeni Automotive Aftermarket Holdings.